【In-depth Analysis: Injective Protocol ($INJ)】 INJ Current Price: Approximately $16.4, a pullback of about 68% from its all-time high of $52 【Layer 1 Financial Chain Positioning】 Injective is a high-performance L1 blockchain built specifically for financial applications, based on the Cosmos SDK. Its core advantages include: - TPS: Over 25,000 in real-world testing, block time approximately 0.6 seconds - Gas Fees: Nearly zero at the network level (chain-level subsidy mechanism) - EVM Compatibility: The inEVM module is online, enabling seamless migration of Ethereum contracts. 【Perpetual Contract Ecosystem】 - Helix (Native DEX): 24-hour perpetual contract trading volume of approximately $480 million, ranking among the top 5 in the entire chain. - Supported Contract Varieties: Over 60 trading pairs including BTC, ETH, SOL, BNB, etc., including innovative varieties such as interest rate swaps and volatility contracts. - On-chain Order Book: Fully decentralized, zero MEV attack (native MEV anti-metabolism mechanism) 【RWA Module Progress】 - Injective RWA Hub: Integrated with gold tokenized assets, US Treasury tokens (tbill), corporate bonds, etc. - Partners: BlackRock BUIDL, Ondo Finance, OpenEden - Current RWA TVL: Approximately $230 million, a year-on-year increase of over 300% 【Contract Security Assessment】 - Audited by Trail of Bits and Certik. - No major vulnerability records; Cosmos IBC cross-chain bridge uses light client verification. 【Comprehensive Assessment】INJ is the purest L1 asset with a DeFi derivatives + RWA dual narrative. Its current valuation is historically undervalued in the financial blockchain sector, and the SEC's support for tokenization provides an additional catalyst. Data Source: Binance Skills Hub, for reference only, not investment advice. #Injective #INJ #RWA #PerpetualContract #Layer1